Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1463326

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1463326

Global Oligonucleotide Synthesis Market Size, Share, Growth Analysis, By End-use(Academic Research Institutes, Diagnostic Laboratories), By Application(PCR Primers, PCR Assays and Panels) - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global oligonucleotide synthesis market size was valued at USD 4.60 billion in 2022 and is poised to grow from USD 5.16 billion in 2023 to USD 12.86 billion by 2031, at a CAGR of 12.10% during the forecast period (2024-2031).

The oligonucleotide synthesis market serves the needs of researchers, scientists, and manufacturers by offering customized and pre-manufactured oligonucleotides for various purposes, including gene synthesis, PCR, DNA sequencing, diagnostics, and therapeutics. A primary driver of this market is the rising demand for synthetic biology and personalized medicine, fueled by advancements in genetic research. Additionally, the growing incidence of cancer and genetic disorders contributes to the market's growth. However, the oligonucleotide synthesis market encounters challenges such as ensuring quality control, adhering to regulatory standards, and addressing ethical concerns related to gene synthesis. Moreover, the increasing complexity of oligonucleotide synthesis and the requirement for specialized equipment and expertise present significant hurdles for market participants. Despite these challenges, the market offers opportunities for innovation, including the development of new synthesis technologies and expanding the application areas for oligonucleotides. Furthermore, the rising demand for personalized medicine and gene therapy creates avenues for market expansion. Overall, while the oligonucleotide synthesis market is poised for continued growth, it may encounter obstacles related to cost, technical proficiency, quality assurance, and regulatory compliance.

Top-down and bottom-up approaches were used to estimate and validate the size of the global oligonucleotide synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oligonucleotide Synthesis Market Segmental Analysis

The global oligonucleotide synthesis market is segmented based on end-use, application, and region. By end-use, the market is segmented into academic research institutes, diagnostic laboratories, and pharmaceutical - biotechnology companies. By application, the market is segmented into PCR primers, PCR assays and panels, sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), Antisense oligonucleotides, and other applications. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Oligonucleotide Synthesis Market

The global oligonucleotide synthesis market is being propelled by the increasing need for oligonucleotides in drug development and diagnostics. Oligonucleotides such as PCR primers, antisense oligonucleotides, and siRNA are extensively utilized in these fields, contributing to the market's growth.

Restraints in the Global Oligonucleotide Synthesis Market

The oligonucleotide synthesis market faces a notable hurdle due to the high cost associated with the synthesis process. This complexity necessitates specialized equipment and expertise, thereby increasing the manufacturing expenses for oligonucleotides.

Market Trends of the Global Oligonucleotide Synthesis Market

The demand for tailored oligonucleotides has been on the rise, catering to specific applications in fields like research, diagnostics, and therapeutics. This trend is driven by the expanding utilization of oligonucleotides in drug development, genetic testing, and personalized medicine. Integrated DNA Technologies, a prominent supplier of customized oligonucleotides, exemplifies this trend by offering a diverse array of oligonucleotides tailored for various research, diagnostic, and therapeutic purposes.

Product Code: SQMIG35H2107

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Oligonucleotide Synthesis Market by End-use

  • Market Overview
  • Academic Research Institutes
  • Diagnostic Laboratories
  • Pharmaceutical Biotechnology Companies

Global Oligonucleotide Synthesis Market by Application

  • Market Overview
  • PCR Primers
  • PCR Assays and Panels
  • Sequencing
  • DNA Microarrays
  • Fluorescence in Situ Hybridization (FISH)
  • Antisense Oligonucleotides
  • and Other Applications

Global Oligonucleotide Synthesis Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Agilent Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioAutomation Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biosearch Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biolytic Lab Performance Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Genomics LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • General Electric Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GenScript Biotech Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integrated DNA Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kaneka Eurogentec S.A. (Belgium)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LGC Limited (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nitto Denko Avecia Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TriLink BioTechnologies, LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Twist Bioscience Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ATDBio Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Axil Scientific Pte Ltd. (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biogen International GmbH (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomer Technology LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Synthesis, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!